Similar Search Results

Designing pro-health competition policies in developing countries

Ido, Vitor Henrique Pinto - 2020

Persistent link: https://www.econbiz.de/10012433548

Special Section 301: US interference with the design and implementation of national patent laws

Correa, Carlos M. - 2020

Persistent link: https://www.econbiz.de/10012433847

Product patents and access to innovative medicines in a post-trips-era

Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019

This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era …. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members − except least-developed country members (LDCs) - to … to be compliant with this provision of TRIPS by 2005. This study investigates two questions in this context: (1) How does …

Persistent link: https://www.econbiz.de/10011992779

The impact of patents on innovation, technology transfer and health : a pre- and post-TRIPs analysis of India's pharmaceutical industry

Horner, Rory - In: New political economy 19 (2014) 3, pp. 384-406

Persistent link: https://www.econbiz.de/10010419020

Compulsory licensing as a remedy against excessive pricing of life-saving medicines

Kianzad, Behrang - 2024

extreme urgency" within the meaning of Article 31(b) of the TRIPS Agreement. Some legislations, such as European competition …

Persistent link: https://www.econbiz.de/10014541546

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - 2016

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...

Persistent link: https://www.econbiz.de/10011509446